A self micro-emulsifying mouth dissolving film (SMMDF) is a dosage form which is based on mouth dissolving film integrated with self micro emulsifying components. Stability of self-micro emulsifying drug delivery system is one of major problem of lipid based drug delivery system. This can be minimized by converting liquid self micro emulsifying drug delivery system into solid SMMDF. This drug delivery system enjoys both advantages of self micro emulsifying drug delivery system (SMEDDS) along with mouth dissolving film (MDF). Self micro-emulsifying mouth dissolving film formulations can be used to improve the oral bioavailability of hydrophobic drugs due to their efficiency of presenting the hydrophobic drug in solubilized form. This review article tries to describe the formulation of MDF and also talks about the SMEDDS. Some of the patented preparations of SMEDDS are also listed.
INTRODUCTION
Systemic absorption of drug is based on factor such as route of administration for a drug. Parenteral administration has some disadvantages such as it requires strict aseptic procedures for preparation. Parenteral route gives pain at the site of injection. Admini stration of drug by oral route is the most effective, noninvasive, adaptable, and accept able route. Oral route has better therapeutic efficacy, low cost and good patient com pliance. 1 In the oral cavity, the delivery of drug may be by intraoral sublingual, intraoral buccal, and peroral. Intraoral sublingual is administration through the mucosa of mouth below the tongue. Intraoral buccal is passage through the mucosa of cheeks and peroral is passage through the mouth to the gastro intestinal tract (GI tract). The peroral route is commonly used. Certain drug after peroral administration gets hydro lyzed due to acid in stomach. Some drugs may degrade due to enzymes, some drug gets presystemic metabolism. These can reduce bioavailability. The insolubility, hydrophobic nature of certain drug may reduce their absorption. Intraoral route has many advan tages over peroral route. 1. The oral mucosa is rich in blood vessels that do not drain into the portal circulation. Drug directly enters the systemic circula tion by the jugular vein. Thus avoiding first pass effects.
drug to cross the cell membrane. Transfer of drug is proportional to the difference in concentration and solubility, carried into the epithelial membranes. The transfer by the oral mucosa is related to molecular size and ionization. Unionized molecules or molecules that have neutral electrical charge give more absorption. The orally disintegrating tablet or ODT 3 meets the European Medicines Agency recommendation. Admini stration of ODTs is easy and there is no need to swallow large particles or water. The required disintegration time of ODTs has to be less than 30 seconds which needs much care during the manufacturing. Compression force and hardness of the tablet are critical parameters of manufacturing of ODTs. Compression force is too high then disintegration time increases than the estab lished limit. Compression force is low then mechanical properties of the tablet will be weak. It gives fragile and brittle tablets of low resistance to mechanical shocks. The most recent researches in the field of orally dissolving solid dosage forms have been dealing with oral thin film technology (OTF) which is a relatively new area of inter est in the oral administration. The first commercial success of oral thin films appeared in the United States (Listerine Pocket Paks). Nowadays several products, manufactured by this technology, have reached the market or are in the clinical phase of development. OTFs have some advan tages over ODTs. The mechanical properties of the films are better than those of ODTs due to their flexibility. OTFs have higher surface for contact with the saliva, so dissolution can be faster. 4 OTFs have an established shelflife of 3 years, depending upon drug but are sensitive to moisture. 5 The various synonyms used for Fast dissolving films (FDFs) include mouth dissolving films (MDFs), melt in-mouth films, oro-dispersible, quick dissolving and rapid disintegrating films, orally disintegrating films (ODFs), 6, 7 orally dissolving strip. 
Mouth dissolving film:
The oral films are essentially complex polymeric matrices that can use efficiently as drug delivery system. These polymeric matrix are com posed by several components in order to achieve well designed drugdelivery. Table 1 gives idea about compo sition of fast dissolving film. A fast-dissolving film is a film containing drug that dissolves or disintegrates in the saliva remarkably fast, without the need for water or chewing. Some drugs are absorbed well from the mouth, pharynx and oesoph agus as the saliva passes down into the stomach. The bioavailability of drug is significantly improved. Mouth dissolving film typically designed for oral administration, with the user placing the strip on or under the tongue or along the inside of the cheek. Classification of mouth dissolving strips: 10 Poor solubility and ultimately low dissolution rate of these drugs in the gastro-intestinal fluids cause poor bioavail ability. For BCS class II drugs, the bioavailability may be enhanced by increasing the solubility and dissolution rate of these drugs in the gastro-intestinal fluids.
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Lipid-based drug delivery system (LBDDS) plays an important role in the delivery of hydrophobic drugs with low bioavailability by using lipids as carriers.
12 Lipidbased drug delivery systems have gained considerable interest after the commercial success of Sand immune Neoral, Novartis Pvt. Ltd., Fortovase and Roche Laboratories Inc with much attention focused on self microemulsifying drug delivery systems (SMEDDS). SMEDDS systems are composed of oil, surfactant and co surfactant. Upon mild agitation followed by dilution in an aqueous medium (gastrointestinal fluids), this system can form fine oil-in-water (o/w) microemulsion. The small droplet size provides a large surface area for drug release and absorption. 13 SMEDDS enhances drug dissolution and improves stability of drug.
14 SMEDDS has great ability to enhancing oral bioavailability of poorly water soluble drugs. Droplet size is increases as the quantity of oil in SMEDDS formulation increases. 15 The absorption after oral administration of the drug from SMEDDS depends on surfactant concentration, oil/surfactant ratio, charge and droplet size.
16 SMEDDS with Labrafil as oil, propylene glycol as surfactant and Cremophor RH40 as co surfactant have provided the greatest bioavailability. 17, 18 Pseudoternary phase diagrams have been used to evaluate the micro emulsification area. 19 Self emulsifying drug delivery systems (SEDDS) also comes under the LBDDS. SEDDS has different characteristics. Information about characteristics of SEDDS, SMEDDS is depicted in Table 2 .
Formulation of SMEDDS:
The synthetic hydro philic oils and surfactants provide good solu C.Then centrifuge at 3500 rpm for 20 minutes. The 1 ml supernatants are separated and dissolve in methanol or alcohol and solubility is quantified by UV-spectro photometer at specific wavelength after appropriate dilution with methanol or alcohol. Select oil, surfactant and co solvent: Based on the solubility of drug oil, surfactant and co solvent is selected. Select ratio of surfactant to co-surfactant: Fixing the surfactant/co-surfactant ratio as 1:1 is a better choice for the stability of SMEDDS. Construction of Phase Diagram: Construct phase diagrams to obtain the proportion of components that can result in maximum microemulsion existence area. Chemix software can be used for this. Construct diagrams with oil, surfactant/co-surfactant (Smix) and water (pseudo-ternary phase diagram) by using water titration method at room temperature. The procedure consists of preparing solutions containing different ratio of surfactant to co-surfactant by weight such as 1:1, 2:1, 3:1 etc. Mix solutions by vortex shaker for 5 minutes and place at 50°C for 1 hour. Then an isotropic mixture can obtain. Each of these solutions used for preparing a mixture containing oil and Smix (mixture of surfactant and co-surfactant) in the following ratios by weight: 1:9, 2:8, 3:7, 4:6, 5:5, 6:4,7:3, 8:2, 9:1. Then mix with vortex mixer for 5 minutes and place in an oven at 50°C for 1 hour. All the mixtures then place at room tempera ture for 24 hours. Add water from 5% to 95% to the mixture. Stir on magnetic stirrer. After each addition of water, observe the mixture for its appearance (turbid or clear). Turbidity of the samples indicates formation of a coarse emulsion. A clear isotropic solution indicates the formation of a micro emulsion. The formation of micro emulsion regions was monitored visually for turbidity-transparency-turbidity.
Preparation of SMEDDS:
Optimize ratio of surfactant to co-surfactant from the phase diagram with bigger area. Weigh surfactant and cosurfactant accurately and vortex for 5-10 minutes. Place Smix in an oven at 50°C for 1 hour. Add oil with different ratio to Smix. Then mix by vortex shaker for 5-10 minutes. Place in oven at 50°C for 1 hour to form an isotropic mixture. Add drug to these isotropic formulations and mix by vortex shaker until a clear solution is obtained. 
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Evaluation of Liquid SMEDDS: Visual observation, phase separation of microemulsion: Each formulation of SMEDDS containing drug is diluted with 250 ml of distilled water at 37 0 C to check visual appearance. Mix the preparation in vortex shaker for 5 minutes and store the mixture for 24 hours. Observe visually phase separation and precipitation. Use those formulations exhibiting a negligible phase separation for further study. Self-emulsification efficiency test: Assess the selfmicro emulsification efficiency of drug loaded SMEDDS using a standard USP dissolution apparatus II. Assess the self-emulsification performance of each SMEDDS visually by using different grading systems like grades A, B, C, D and E. Grade A: Rapidly forming (within 1 min) microemulsion, having a clear or bluish appearance. Grade B: Rapidly forming, slightly less clear emulsion, having a bluish white appearance. Grade C: Fine milky emulsion formed within 2 minutes. Grade D: Dull, grayish white emulsion having slightly oily appearance that is slow to emulsify (longer than 2 minutes).
Grade E: Formulation, exhibiting either poor or minimal emulsification with large oil globules present on the surface. Recommend Grade A, Grade B formulation as micro emulsion when dispersed in GIT. Recommend Grade C for SEDDS formulations. Thermodynamic stability test: Optimize formulations then subjected to different thermodynamic stability study tests namely centrifugation and freeze thaw cycles. % transmittance test: Reconstitute the SMEDDS with distilled water (1:100). Observe the resulting microemul sion for any precipitation. Measure % transmittance at 640.2 nm using UV-visible spectrophotometer. Globule size and PDI: Determine the globule size and PDI of reconstituted drug loaded SMEDDS using Malvern Zetaseizer. Zeta-potential: Determine the zeta potential of formu lations by laser diffraction analysis using particle size analyzer (Malvern Zetasizer Nano series ZS 90 UK). Drug Content: Determine the percentage drug content of formulations from the calibration curve by using UV. Viscosity: Evaluate the viscosity of optimized formulation by Brookfield viscometer. In vitro dissolution studies: Perform in vitro dissolu tion/drug release studies in 900 ml of 0.1 N HCL using USP method (dissolution apparatus II) at 100 rpm and 37 ± 0.5°C.
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Features of SMMDF
• It is free from obstructions.
• It gives good mucoadhesion.
• It gives rapid disintegration (within 5-30 sec).
• It releases the drug quickly.
Advantages of SMMDF
• Quick onset of action as compared to tablet.
• Does not require water during administration.
• Taste masking is possible by using different sweet ening agents.
• There is no risk of chocking.
• It offers good stability.
• It offers patient compliance.
• Rapid disintegrating and dissolution.
• Flexible and portable nature gives ease in transpor tation, storage, and handling.
• Avoids first past metabolism.
Disadvantages of SMMDF
• Only low dose drug can be incorporated (less than 30 mg).
• Dose uniformity is a challenge.
• It takes moisture from atmosphere.
• It requires special packaging for product's stability and safety.
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Drug selection for SMMDF
SMMDF is useful for Biopharmaceutical classi fication system BCS Class II and IV. Drug lipo philicity (log P) is useful for design of SMMDF. High logP of drug (greater than 4) is desirable. Drugs which have low solubility in water or lipids are difficult to deliver through SMMDF. Drugs which are administered in very high dose are not suitable for formu lation unless they have extremely good solubility in at least one of the components of SMEDDS, preferably in oil phase. High melting point drugs with log P values of about 2 are poorly suited to SMMDF. At the other end of the spectrum, lipophilic drugs, such as cinnari zine with log P values greater than 5, are good candidate for SMMDF. The melting point acts as a surrogate for the product of solubility and partition coefficient. It allows one to assess whether a drug is likely to be well absorbed or not at a given dose level. In general, low melting com pounds will be better absorbed than high melting point compounds. For every one hundred degrees increase in melting temperature, there is a 10fold decrease in the maximum dose that will provide at least 50% absorption. So low melting point and low dose of drug is desirable for formulation of SMEDDS and SMMDF. Examples of drug that can be used for formulation of SMMDF are Anticancer (Paclitaxel), Antihyperlipidemic (Fluvastatin, Ezetimibe), Immunosuppressive (Rapamycin, Cyclosporine), Antihypertensive (Nifedipine), Analgesic (ibuprofen, Naproxen, Piroxicam, Meloxicam, Indometh acin), Hormones (Progesterone, Testosterone), Antiviral (Acyclovir), Immunomodulatory (Melatonin), Antima larial (Artemether), antidiabetic (glibenclamide).
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Manufacturing methods of SMMDF
Manufacturing methods are same as that of mouth dis solving film (Figure 1 ). Solvent Casting Method: Dissolve the water soluble polymers in suitable solvent and Dissolve the drug along with other excipients in suitable solvent. Mix and stir both solutions and caste into the Petri plate and dry. Semisolid Casting Method: Dissolve the water soluble polymers in suitable solvent. Add this solution to a solu tion of acid insoluble polymer (E.g. cellulose acetate phthalate, cellulose acetate butyrate). The ratio of the acid insoluble polymer to film forming polymer should be 1:4. Add appropriate amount of plasticizer to obtained gel mass. Cast gel mass into the films or ribbons using heat controlled drums. 
Flexoprinting or Flexographic printing technology (FPT):
FPT is a process that transfers drug into thin films gently via contact printing. The flexographic printing is a rotary printing process. Measure ink consisting of drug substance solution and suspension by an anilox roller then are transferred to a printing cylinder that prints the film after unwinding the daughter roll. It is useful for heat sensitive products like proteins and peptides. The production efficiency is high as the pro duction rate of 530 oral films per minute. Hence this process is used to scaleup production. Inkjet printing: Inkjet printing is the recently devel oped technology, which is characterized by its versatility, accuracy, repeatability and relatively inexpensive method that deposits small volumes of solution in films. Inkjet printing is extensively applicable for the preparation of low dose drug and also offers an opportunity to manufacture personalized medicines. Dissolve the drug in a solution (ink) with optimal properties (viscosity and surface tension) for printability. After deposition by printing, Separate the printed patterns by cutting and inserting into capsule shells or folded to form the final therapeutic dosage forms or coated in an appropriate manner.
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Formulation steps for SMMDF Figure 2 gives idea about formulation of SMMDF. Evaluate polymer according to Film forming capabil ity. Choose the polymer which gives proper disintegra tion time with good film forming capability. Optimize the quantity for polymer and plasticizer. Prepare cast ing solution by dissolving polymer, plasticizer, sweet ener, flavor, and color in water. Transfer appropriate volume of SMEDDS solution containing drug into a casting solution. Mix it well. Remove air that entrapped in solution. Dry the casting solution in Petri plate. Cut dosage form into proper size to obtain the desired amount of drug. Pack and store in aluminum foil.
Evaluation of SMMDF
Film thickness: This is essential to ascertain uniformity in the thickness of the film as this is directly related to the dose in the strip. Calculate film thickness by using microm eter screw gauge at 5 different strategic locations.
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Tensile strength: Evaluate tensile strength of the patch by using the tensilometer. It consists of two load cell grip, the lower one is fixed and upper one is movable. Film with dimensions of 2×2 cm 2 is fixed between cell grips and force gradually applied till the film break. Take tensile strength reading directly from the dial in kg. Folding endurance: Determine folding endurance by repeated folding of the strip at the same place till the strip breaks. Disintegration time: Keep six strips in the disintegration tester at room temperature in tubes in the environment of water until they disintegrate and measure time. Disintegration time will vary depending on the formulation Table 3 gives information related to Mouth dissolving film patents.
CONCLUSION
Self-emulsifying mouth dissolving film is promising approach for the formulation of drugs with poor aqueous solubility, high molecular weight, pre systemic first pass effect, enzymatic degradation, gastric irritation, limited dissolution rate and low bioavailability. SMMDF is used to improve dissolution characteristics of a poorly water solu ble drug as it maintains the drug in a solubilized form and has quick onset of action. SolidSMEDDS is also a solid dosage form but it cannot avoid first pass metabolism of drug. SMMDF is economic as it requires less quantity of drug and less complicated machineries. SMMDF appear to be unique and industrially feasible approach to over come the problem of low oral bioavailability associated with the lipophilic drugs. This study explores the possi bilities of loading a wide variety of plant actives as their scale up is convenient and economical.
• A self micro-emulsifying mouth dissolving film (SMMDF) is a dosage form which is based on mouth dissolving film integrated with self micro emulsifying components. Self-emulsifying mouth dissolving film is promising approach for the formulation of drugs with poor aqueous solubility, high molecular weight, pre systemic first pass effect, enzymatic degradation, gastric irritation, limited dissolution rate and low bioavailability. SMMDF is economic as it requires less quantity of drug and less complicated machineries. SMMDF appear to be unique and industrially feasible approach to overcome the problem of low oral bioavailability associated with the lipophilic drugs.
SUMMARY
